dextroamphetamine has been researched along with Disease Models, Animal in 184 studies
Dextroamphetamine: The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
(S)-amphetamine : A 1-phenylpropan-2-amine that has S configuration.
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Several clinical reports have suggested that the mirtazapine-induced augmentation of risperidone activity may effectively improve the positive, negative and some cognitive symptoms of schizophrenia." | 7.78 | Effect of co-treatment with mirtazapine and risperidone in animal models of the positive symptoms of schizophrenia in mice. ( Rogóż, Z, 2012) |
| "Intrastriatal injection of 3-nitropropionic acid results in secondary excitotoxic local damage and retrograde neuronal cell loss in substantia nigra pars compacta, thus mimicking salient features of striatonigral degeneration, the core pathology underlying Parkinsonism associated with multiple system atrophy." | 7.71 | No functional effects of embryonic neuronal grafts on motor deficits in a 3-nitropropionic acid rat model of advanced striatonigral degeneration (multiple system atrophy). ( Jellinger, K; Poewe, W; Puschban, Z; Scherfler, C; Seppi, K; Waldner, R; Wenning, GK, 2001) |
| "Neuropeptide Y (NPY), has been implicated in the pathophysiology of depression and the mechanisms of action of electroconvulsive treatment (ECT)." | 7.70 | Neuropeptide Y in brains of the Flinders Sensitive Line rat, a model of depression. Effects of electroconvulsive stimuli and d-amphetamine on peptide concentrations and locomotion. ( Ahlenius, S; Jiménez Vasquez, PA; Mathé, AA; Salmi, P, 2000) |
| " This study examines the effects of chronic lithium administration on changes induced by amphetamine administration and withdrawal on open field locomotor activity of rats, and considered as an animal model of behaviors displayed in bipolar disorders." | 7.68 | Effects of lithium on an amphetamine animal model of bipolar disorder. ( Cappeliez, P; Moore, E, 1990) |
| "Haloperidol and clozapine were tested in rats after daily administration for 3 and 21 days in combination with vehicle or PCP (2." | 5.30 | A test of the predictive validity of animal models of schizophrenia based on phencyclidine and D-amphetamine. ( Sams-Dodd, F, 1998) |
| " Then, we combined it with different doses of psychostimulants (d-amphetamine, modafinil, caffeine) to find the best combination for motion sickness." | 3.83 | The Combination of Scopolamine and Psychostimulants for the Prevention of Severe Motion Sickness. ( Han, B; Liu, AJ; Liu, HQ; Song, XR; Tian, JS; Yu, XH; Zhang, LL; Zhang, Y, 2016) |
| "One of the most devastating consequences of methamphetamine abuse is increased risk of psychosis." | 3.83 | BDNF-Deficient Mice Show Reduced Psychosis-Related Behaviors Following Chronic Methamphetamine. ( Halberstadt, AL; Manning, EE; van den Buuse, M, 2016) |
| " Since protein kinase C (PKC) activity has been implicated in the pathophysiology of bipolar disorder and the biochemical effects of mood stabilizers, the new PKC inhibitor myricitrin (10, 30 mg/kg) was also evaluated." | 3.80 | Amphetamine-induced appetitive 50-kHz calls in rats: a marker of affect in mania? ( Andreatini, R; Brenes, JC; Pereira, M; Schwarting, RK, 2014) |
| "Several clinical reports have suggested that the mirtazapine-induced augmentation of risperidone activity may effectively improve the positive, negative and some cognitive symptoms of schizophrenia." | 3.78 | Effect of co-treatment with mirtazapine and risperidone in animal models of the positive symptoms of schizophrenia in mice. ( Rogóż, Z, 2012) |
| "The purpose of the current experiments was to examine the anxiety-related effects of repeated amphetamine and nicotine administration using the mouse elevated plus maze (EPM)." | 3.74 | Calcium channel antagonists suppress cross-tolerance to the anxiogenic effects of D-amphetamine and nicotine in the mouse elevated plus maze test. ( Biala, G; Kruk, M, 2008) |
| " Lower doses of valproate and carbamazepine were required to prevent hyperactivity compared to doses required to block tonic-clonic seizures induced by pentylenetetrazole." | 3.73 | Evaluation of the effects of lamotrigine, valproate and carbamazepine in a rodent model of mania. ( Arban, R; Brackenborough, K; Gerrard, P; Large, C; Maraia, G; Wilson, A; Winyard, L, 2005) |
| "Intrastriatal injection of 3-nitropropionic acid results in secondary excitotoxic local damage and retrograde neuronal cell loss in substantia nigra pars compacta, thus mimicking salient features of striatonigral degeneration, the core pathology underlying Parkinsonism associated with multiple system atrophy." | 3.71 | No functional effects of embryonic neuronal grafts on motor deficits in a 3-nitropropionic acid rat model of advanced striatonigral degeneration (multiple system atrophy). ( Jellinger, K; Poewe, W; Puschban, Z; Scherfler, C; Seppi, K; Waldner, R; Wenning, GK, 2001) |
| "Excepting clozapine and DOD 647, all drugs induced dystonia." | 3.70 | New and old antipsychotics versus clozapine in a monkey model: adverse effects and antiamphetamine effects. ( Gerlach, J; Peacock, L, 1999) |
| "Neuropeptide Y (NPY), has been implicated in the pathophysiology of depression and the mechanisms of action of electroconvulsive treatment (ECT)." | 3.70 | Neuropeptide Y in brains of the Flinders Sensitive Line rat, a model of depression. Effects of electroconvulsive stimuli and d-amphetamine on peptide concentrations and locomotion. ( Ahlenius, S; Jiménez Vasquez, PA; Mathé, AA; Salmi, P, 2000) |
| " This study examines the effects of chronic lithium administration on changes induced by amphetamine administration and withdrawal on open field locomotor activity of rats, and considered as an animal model of behaviors displayed in bipolar disorders." | 3.68 | Effects of lithium on an amphetamine animal model of bipolar disorder. ( Cappeliez, P; Moore, E, 1990) |
| ", thigmotaxis) was suppressed by anxiolytic agents (diazepam 1-5 mg/kg; chlordiazepoxide 1-10 mg/kg; pentobarbital 1-10 mg/kg), with a relative potency that was similar to their relative potency in the treatment of human anxiety." | 3.67 | Thigmotaxis as a test for anxiolytic activity in rats. ( Fundytus, M; Treit, D, 1988) |
| " The appearance of dyskinetic movement disorders in humans following the chronic use of levodopa or amphetamine may be a manifestation of similarly increased dopamine receptor site sensitivity within the striatum." | 3.65 | Supersensitivity to d-amphetamine- and apomorphine-induced stereotyped behavior induced by chronic d-amphetamine administration. ( Crosset, P; Dana, N; Klawans, HL; Margolin, DI, 1975) |
| "Schizophrenia is a chronic severe mental disorder with a presumed neurodevelopmental origin, and no effective treatment." | 1.43 | Genetic blockade of adenosine A2A receptors induces cognitive impairments and anatomical changes related to psychotic symptoms in mice. ( Ciruela, F; Gracia-Rubio, I; Moscoso-Castro, M; Valverde, O, 2016) |
| "In the present study, by combining the psychostimulant-induced model of mania in rodents with the recently developed ambiguous-cue interpretation (ACI) tests, we investigated the effects of chronic administration of D-amphetamine and cocaine on the cognitive judgment bias of rats." | 1.42 | Cognitive judgment bias in the psychostimulant-induced model of mania in rats. ( Golebiowska, J; Kregiel, J; Kubik, J; Popik, P; Rygula, R; Szczech, E, 2015) |
| " CD-1 mice were subcutaneously dosed for 5 days with 1." | 1.42 | Amphetamine sensitization in mice is sufficient to produce both manic- and depressive-related behaviors as well as changes in the functional connectivity of corticolimbic structures. ( Baker, K; Ibrahim, BA; Kelly, MP; McCarthy, SA; Pathak, G, 2015) |
| " Chronic administration of lithium chloride or valproic acid, two clinically effective mood stabilizers, reverses the majority of these behavioral abnormalities." | 1.42 | Mice heterozygous for cathepsin D deficiency exhibit mania-related behavior and stress-induced depression. ( Duan, S; Han, Y; Li, X; Lou, H; Lu, Y; Zhen, X; Zhou, R; Zhu, L, 2015) |
| "Hence, we used a Parkinson's disease animal model based on unilateral injection of a recombinant adeno-associated viral vector encoding α-synuclein in the rat midbrain." | 1.39 | Chronic intranasal deferoxamine ameliorates motor defects and pathology in the α-synuclein rAAV Parkinson's model. ( Andersen, KJ; Febbraro, F; Romero-Ramos, M; Sanchez-Guajardo, V; Tentillier, N, 2013) |
| " In the present studies, dose-response curves for d-amphetamine (AMPH)-induced hyperlocomotion were similar in standard B6 mice and in the BTBR mouse model of autism." | 1.39 | Influence of stimulant-induced hyperactivity on social approach in the BTBR mouse model of autism. ( Babineau, BA; Crawley, JN; Karras, MN; Oliver, CF; Silverman, JL, 2013) |
| "During drug development, seizure threshold tests are widely used to identify potential proconvulsant activity of investigational drugs." | 1.38 | Striking differences in proconvulsant-induced alterations of seizure threshold in two rat models. ( Bankstahl, JP; Bankstahl, M; Bloms-Funke, P; Löscher, W, 2012) |
| "Sertraline (10 mg/kg ip) was injected either acutely, or over 5 days of repeated treatment." | 1.38 | Effects of sertraline on experimental mouse models of psychosis. ( Bilge, U; Erol, K, 2012) |
| "Schizophrenia is a debilitating psychotic disorder that affects up to 1." | 1.38 | Assessment of behaviors modeling aspects of schizophrenia in Csmd1 mutant mice. ( Distler, MG; Dulawa, SC; Opal, MD; Palmer, AA, 2012) |
| " After determining a dose-response curve for cocaine (0." | 1.37 | Prolonged attenuation of the reinforcing strength of cocaine by chronic d-amphetamine in rhesus monkeys. ( Czoty, PW; Gould, RW; Martelle, JL; Nader, MA, 2011) |
| "pramipexole) known to produce compulsive behaviors in humans would increase marble burying." | 1.37 | Pharmacological evaluation of the adequacy of marble burying as an animal model of compulsion and/or anxiety. ( Jimenez-Gomez, C; Osentoski, A; Woods, JH, 2011) |
| "Mild catalepsy was observed at 30 mg/kg, being more pronounced at 50 mg/kg and 100 mg/kg." | 1.33 | Atypical antipsychotic profile of flunarizine in animal models. ( Dall'Igna, OP; de Oliveira, RV; Fett, P; Gomes, MW; Lara, DR; Mantese, CE; Schuh, J; Souza, DO; Tort, AB, 2005) |
| "Haloperidol and clozapine were tested in rats after daily administration for 3 and 21 days in combination with vehicle or PCP (2." | 1.30 | A test of the predictive validity of animal models of schizophrenia based on phencyclidine and D-amphetamine. ( Sams-Dodd, F, 1998) |
| "Signs of motion sickness were scored using a rating scale." | 1.28 | Investigation of anti-motion sickness drugs in the squirrel monkey. ( Cheung, BS; Kinter, LB; Kohl, RL; Money, KE, 1992) |
| "Three main symptoms of minimal brain dysfunction (MBD), a common disorder in children, are hyperactivity, learning disabilities, and attention deficits." | 1.26 | An evaluation of the young dopamine-lesioned rat as an animal model for minimal brain dysfunction (MBD). ( Dijkstra, H; Stoof, JC; Thieme, RE, 1980) |
| "In order to determine whether alterations in sensitivity to rewarding stimuli accompany the biochemical and behavioral changes induced by chronic amphetamine treatment and withdrawal, we explored the effects of chronic administration and withdrawal of d-amphetamine on thresholds of intracranial reinforcement in the rat." | 1.26 | Amphetamine withdrawal: effects on threshold of intracranial reinforcement. ( Actor, C; Cassens, G; Kling, M; Schildkraut, JJ, 1981) |
| "In respect to myoclonus, clonidine persisted in producing effects similar to those seen in the long-sleep mice whereas apomorphine exhibited the same ontogenetic alteration in effect seen with amphetamine." | 1.26 | Paradoxical effects of d-amphetamine upon seizure susceptibility in 2 selectively bred lines of mice. ( Alpern, HP; Greer, CA, 1980) |
| "We conclude that phenytoin induced hyperkinesias reflect a specific effect of phenytoin on an abnormal neural substrate and suggest the presence of an otherwise silent pathological alteration of the corpus striatum." | 1.26 | Clinical and experimental studies of phenytoin-induced hyperkinesias. ( Klawans, HL; Koller, WC; Nausieda, PA; Weiner, WJ, 1979) |
| "Controversial multiple investigations have reported that chronic administration of amphetamine or similar drugs in different animals produces a reverse tolerance or a receptor hypersensitivity." | 1.26 | Dopamine receptors hypersensitivity: further confirmation following drug abuse model. ( Flemenbaum, A, 1977) |
| "The authors conducted a study in which schizophrenic-like behavioral disturbances were induced in members of a macaque social colony by the chronic administration of d-amphetamine." | 1.25 | A schizophreniform behavioral psychosis mediated by dopamine. ( Davis, JM; Garver, DL; Maas, JW; Schlemmer, RF, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 56 (30.43) | 18.7374 |
| 1990's | 27 (14.67) | 18.2507 |
| 2000's | 39 (21.20) | 29.6817 |
| 2010's | 59 (32.07) | 24.3611 |
| 2020's | 3 (1.63) | 2.80 |
| Authors | Studies |
|---|---|
| Wolinsky, TD | 1 |
| Swanson, CJ | 1 |
| Smith, KE | 1 |
| Zhong, H | 1 |
| Borowsky, B | 1 |
| Seeman, P | 2 |
| Branchek, T | 1 |
| Gerald, CP | 1 |
| Lee, DW | 1 |
| Ryu, YK | 1 |
| Chang, DH | 1 |
| Park, HY | 1 |
| Go, J | 1 |
| Maeng, SY | 1 |
| Hwang, DY | 1 |
| Kim, BC | 1 |
| Lee, CH | 1 |
| Kim, KS | 1 |
| Abe, H | 1 |
| Jitsuki, S | 1 |
| Takahashi, T | 1 |
| Valvassori, SS | 13 |
| Tonin, PT | 3 |
| Dal-Pont, GC | 4 |
| Varela, RB | 10 |
| Cararo, JH | 1 |
| Garcia, AF | 1 |
| Gava, FF | 3 |
| Menegas, S | 1 |
| Soares, JC | 2 |
| Quevedo, J | 15 |
| Chaves Filho, AJM | 1 |
| Cunha, NL | 1 |
| Rodrigues, PA | 1 |
| de Souza, AG | 1 |
| Soares, MV | 1 |
| Jucá, PM | 1 |
| de Queiroz, T | 1 |
| Clemente, DCDS | 1 |
| Mottin, M | 1 |
| Andrade, CH | 1 |
| Peixoto, CA | 1 |
| Macedo, DS | 2 |
| Fitzpatrick, CM | 1 |
| Maric, VS | 1 |
| Bate, ST | 1 |
| Andreasen, JT | 1 |
| Brown, CE | 1 |
| Aguilar, B | 1 |
| Starr, R | 1 |
| Yang, X | 1 |
| Chang, WC | 1 |
| Weng, L | 1 |
| Chang, B | 1 |
| Sarkissian, A | 1 |
| Brito, A | 1 |
| Sanchez, JF | 1 |
| Ostberg, JR | 1 |
| D'Apuzzo, M | 1 |
| Badie, B | 1 |
| Barish, ME | 1 |
| Forman, SJ | 1 |
| Rojas-Leguizamón, M | 1 |
| Baroja, JL | 1 |
| Sanabria, F | 1 |
| Orduña, V | 1 |
| Jackson, C | 1 |
| van Staaden, M | 1 |
| Mariot, E | 3 |
| Bavaresco, DV | 1 |
| Ferreira, CL | 5 |
| Andersen, ML | 6 |
| Tye, SJ | 1 |
| Openshaw, RL | 1 |
| Thomson, DM | 1 |
| Thompson, R | 1 |
| Penninger, JM | 1 |
| Pratt, JA | 1 |
| Morris, BJ | 1 |
| Dawson, N | 1 |
| Rogóż, Z | 1 |
| Wierońska, JM | 2 |
| Acher, FC | 1 |
| Sławińska, A | 1 |
| Gruca, P | 1 |
| Lasoń-Tyburkiewicz, M | 1 |
| Papp, M | 1 |
| Pilc, A | 2 |
| Febbraro, F | 1 |
| Andersen, KJ | 1 |
| Sanchez-Guajardo, V | 1 |
| Tentillier, N | 1 |
| Romero-Ramos, M | 1 |
| Kameda, SR | 1 |
| Fukushiro, DF | 1 |
| Wuo-Silva, R | 1 |
| Trombin, TF | 1 |
| Procópio-Souza, R | 1 |
| Brandão, LC | 1 |
| Sanday, L | 1 |
| Patti, CL | 1 |
| Mári-Kawamoto, E | 1 |
| Tufik, S | 1 |
| D'Almeida, V | 1 |
| Frussa-Filho, R | 1 |
| Reichelt, AC | 1 |
| Good, MA | 1 |
| Killcross, S | 2 |
| Whitney, KN | 1 |
| Wenger, GR | 1 |
| Pereira, M | 1 |
| Andreatini, R | 1 |
| Schwarting, RK | 1 |
| Brenes, JC | 1 |
| Clements, KM | 1 |
| Devonshire, IM | 1 |
| Reynolds, JN | 1 |
| Overton, PG | 1 |
| Rygula, R | 1 |
| Szczech, E | 1 |
| Kregiel, J | 1 |
| Golebiowska, J | 1 |
| Kubik, J | 1 |
| Popik, P | 1 |
| Partyka, A | 1 |
| Jarosz, J | 1 |
| Wasik, A | 1 |
| Jastrzębska-Więsek, M | 1 |
| Zagórska, A | 1 |
| Pawłowski, M | 1 |
| Wesołowska, A | 1 |
| Gubert, C | 1 |
| Fries, GR | 2 |
| Pfaffenseller, B | 1 |
| Ferrari, P | 1 |
| Coutinho-Silva, R | 1 |
| Morrone, FB | 1 |
| Kapczinski, F | 7 |
| Battastini, AMO | 1 |
| Carvalho, AF | 3 |
| Amboni, RT | 1 |
| Bianchini, G | 1 |
| Pathak, G | 1 |
| Ibrahim, BA | 1 |
| McCarthy, SA | 2 |
| Baker, K | 1 |
| Kelly, MP | 1 |
| Fuller, JJ | 1 |
| Murray, RC | 1 |
| Horner, KA | 1 |
| Stenslik, MJ | 1 |
| Potts, LF | 1 |
| Sonne, JW | 1 |
| Cass, WA | 1 |
| Turchan-Cholewo, J | 1 |
| Pomerleau, F | 1 |
| Huettl, P | 1 |
| Ai, Y | 1 |
| Gash, DM | 1 |
| Gerhardt, GA | 1 |
| Bradley, LH | 1 |
| Zhou, R | 1 |
| Lu, Y | 1 |
| Han, Y | 1 |
| Li, X | 1 |
| Lou, H | 1 |
| Zhu, L | 1 |
| Zhen, X | 1 |
| Duan, S | 1 |
| Manning, EE | 1 |
| Halberstadt, AL | 1 |
| van den Buuse, M | 2 |
| Furlong, TM | 1 |
| Leavitt, LS | 1 |
| Keefe, KA | 1 |
| Son, JH | 1 |
| Moscoso-Castro, M | 1 |
| Gracia-Rubio, I | 1 |
| Ciruela, F | 1 |
| Valverde, O | 1 |
| Zhang, LL | 1 |
| Liu, HQ | 1 |
| Yu, XH | 1 |
| Zhang, Y | 1 |
| Tian, JS | 1 |
| Song, XR | 1 |
| Han, B | 1 |
| Liu, AJ | 1 |
| Resende, WR | 3 |
| Arent, CO | 4 |
| Peterle, BR | 1 |
| Castro-Hernández, J | 1 |
| Adlard, PA | 1 |
| Finkelstein, DI | 1 |
| Adkins, DL | 2 |
| Schallert, T | 1 |
| Goldstein, LB | 1 |
| Li, M | 1 |
| He, W | 1 |
| Mead, A | 1 |
| Miranda, F | 1 |
| Jiménez, JC | 1 |
| Cedillo, LN | 1 |
| Sandoval-Sánchez, A | 1 |
| Millán-Mejía, P | 1 |
| Sánchez-Castillo, H | 1 |
| Velázquez-Martínez, DN | 1 |
| Fujiki, N | 1 |
| Cheng, T | 1 |
| Yoshino, F | 1 |
| Nishino, S | 1 |
| van der Staay, FJ | 1 |
| Pouzet, B | 1 |
| Mahieu, M | 1 |
| Nordquist, RE | 1 |
| Schuurman, T | 1 |
| Barbay, S | 2 |
| Nudo, RJ | 2 |
| Yan, TC | 1 |
| Hunt, SP | 1 |
| Stanford, SC | 1 |
| Karl, T | 2 |
| Chesworth, R | 2 |
| Duffy, L | 2 |
| Herzog, H | 2 |
| Young, JW | 1 |
| Goey, AK | 1 |
| Minassian, A | 1 |
| Perry, W | 1 |
| Paulus, MP | 1 |
| Geyer, MA | 1 |
| Mavrikaki, M | 1 |
| Nomikos, GG | 1 |
| Panagis, G | 2 |
| Rezin, GT | 1 |
| Moretti, M | 3 |
| Gonçalves, CL | 1 |
| Cardoso, MR | 1 |
| Streck, EL | 3 |
| Krapacher, FA | 1 |
| Mlewski, EC | 1 |
| Ferreras, S | 1 |
| Pisano, V | 1 |
| Paolorossi, M | 1 |
| Hansen, C | 1 |
| Paglini, G | 1 |
| Beray-Berthat, V | 1 |
| Delifer, C | 1 |
| Besson, VC | 1 |
| Girgis, H | 1 |
| Coqueran, B | 1 |
| Plotkine, M | 1 |
| Marchand-Leroux, C | 1 |
| Margaill, I | 1 |
| Dao, DT | 1 |
| Mahon, PB | 1 |
| Cai, X | 1 |
| Kovacsics, CE | 1 |
| Blackwell, RA | 1 |
| Arad, M | 1 |
| Shi, J | 1 |
| Zandi, PP | 1 |
| O'Donnell, P | 1 |
| Knowles, JA | 1 |
| Weissman, MM | 1 |
| Coryell, W | 1 |
| Scheftner, WA | 1 |
| Lawson, WB | 1 |
| Levinson, DF | 1 |
| Thompson, SM | 1 |
| Potash, JB | 1 |
| Gould, TD | 1 |
| Czoty, PW | 1 |
| Gould, RW | 1 |
| Martelle, JL | 1 |
| Nader, MA | 1 |
| Steckert, AV | 3 |
| Rochi, N | 2 |
| Benedet, J | 2 |
| Scaini, G | 2 |
| Zugno, AI | 3 |
| Profaci, CP | 2 |
| Krolikowski, KA | 1 |
| Olszewski, RT | 2 |
| Neale, JH | 2 |
| Dean, OM | 1 |
| Berk, M | 1 |
| Copolov, DL | 1 |
| Mavros, C | 1 |
| Bush, AI | 1 |
| de Lima, MN | 1 |
| Presti-Torres, J | 1 |
| Vedana, G | 1 |
| Alcalde, LA | 1 |
| Stertz, L | 1 |
| Roesler, R | 1 |
| Schröder, N | 1 |
| da-Rosa, DD | 1 |
| Lopes-Borges, J | 3 |
| Dal-Pizzol, F | 3 |
| Jimenez-Gomez, C | 1 |
| Osentoski, A | 1 |
| Woods, JH | 1 |
| Stachowicz, K | 1 |
| Acher, F | 1 |
| Lech, T | 1 |
| Bankstahl, M | 1 |
| Bankstahl, JP | 1 |
| Bloms-Funke, P | 1 |
| Löscher, W | 1 |
| Bilge, U | 1 |
| Erol, K | 1 |
| Mina, F | 1 |
| Meyer, F | 1 |
| Louilot, A | 1 |
| Zhang, LJ | 1 |
| Xue, YQ | 1 |
| Yang, C | 1 |
| Yang, WH | 1 |
| Chen, L | 1 |
| Zhang, QJ | 1 |
| Qu, TY | 1 |
| Huang, S | 1 |
| Zhao, LR | 1 |
| Wang, XM | 1 |
| Duan, WM | 1 |
| Janczura, KJ | 1 |
| Ball, SR | 1 |
| Madore, JC | 1 |
| Lavin, KM | 1 |
| Lee, JC | 1 |
| Lee, MJ | 1 |
| Der, EK | 1 |
| Hark, TJ | 1 |
| Farago, PR | 1 |
| Bzdega, T | 1 |
| Medeiros, CD | 1 |
| Cordeiro, RC | 1 |
| Sousa, FC | 1 |
| Santos, JV | 1 |
| Morais, TA | 1 |
| Hyphantis, TN | 1 |
| McIntyre, RS | 1 |
| Silverman, JL | 1 |
| Babineau, BA | 1 |
| Oliver, CF | 1 |
| Karras, MN | 1 |
| Crawley, JN | 1 |
| Schmidt, TT | 1 |
| Rea, E | 1 |
| Shababi-Klein, J | 1 |
| Winter, C | 1 |
| Cechinel-Recco, K | 1 |
| Vitto, MF | 1 |
| Luz, G | 1 |
| de Souza, CT | 1 |
| Fraga, DB | 1 |
| Distler, MG | 1 |
| Opal, MD | 1 |
| Dulawa, SC | 1 |
| Palmer, AA | 1 |
| Wang, J | 1 |
| Qian, JK | 1 |
| Wang, BZ | 1 |
| Gao, JY | 1 |
| Shi, HZ | 1 |
| Kliethermes, CL | 1 |
| Finn, DA | 1 |
| Crabbe, JC | 1 |
| Fricker-Gates, RA | 1 |
| Smith, R | 1 |
| Muhith, J | 1 |
| Dunnett, SB | 2 |
| Peterson, JD | 1 |
| Wolf, ME | 1 |
| White, FJ | 1 |
| Tort, AB | 1 |
| Dall'Igna, OP | 1 |
| de Oliveira, RV | 1 |
| Mantese, CE | 1 |
| Fett, P | 1 |
| Gomes, MW | 1 |
| Schuh, J | 1 |
| Souza, DO | 1 |
| Lara, DR | 1 |
| Shukla, S | 1 |
| Agrawal, AK | 1 |
| Chaturvedi, RK | 1 |
| Seth, K | 1 |
| Srivastava, N | 1 |
| Sinha, C | 1 |
| Shukla, Y | 1 |
| Khanna, VK | 1 |
| Seth, PK | 1 |
| Odum, AL | 1 |
| Shahan, TA | 1 |
| Gasior, M | 1 |
| Bergman, J | 1 |
| Kallman, MJ | 1 |
| Paronis, CA | 1 |
| Chudasama, Y | 1 |
| Nathwani, F | 1 |
| Robbins, TW | 1 |
| Arban, R | 1 |
| Maraia, G | 1 |
| Brackenborough, K | 1 |
| Winyard, L | 1 |
| Wilson, A | 1 |
| Gerrard, P | 1 |
| Large, C | 1 |
| Terranova, JP | 1 |
| Chabot, C | 1 |
| Barnouin, MC | 1 |
| Perrault, G | 1 |
| Depoortere, R | 1 |
| Griebel, G | 1 |
| Scatton, B | 1 |
| Jones, TA | 1 |
| Rasmussen, RS | 1 |
| Overgaard, K | 1 |
| Hildebrandt-Eriksen, ES | 1 |
| Boysen, G | 1 |
| Ninkovic, J | 2 |
| Folchert, A | 1 |
| Makhankov, YV | 1 |
| Neuhauss, SC | 1 |
| Sillaber, I | 1 |
| Straehle, U | 1 |
| Bally-Cuif, L | 2 |
| Siuciak, JA | 1 |
| Chapin, DS | 1 |
| Guanowsky, V | 1 |
| Brown, J | 1 |
| Chiang, P | 1 |
| Marala, R | 1 |
| Patterson, T | 1 |
| Seymour, PA | 1 |
| Swick, A | 1 |
| Iredale, PA | 1 |
| Frey, BN | 1 |
| Réus, GZ | 1 |
| Martins, MR | 1 |
| Petronilho, FC | 1 |
| Bardini, K | 1 |
| Zoubina, EV | 1 |
| Dancause, N | 1 |
| Frost, SB | 1 |
| Eisner-Janowicz, I | 1 |
| Stowe, AM | 1 |
| Plautz, EJ | 1 |
| Rivalan, M | 1 |
| Grégoire, S | 1 |
| Dellu-Hagedorn, F | 1 |
| Ferreira, MT | 1 |
| Ferreira, R | 1 |
| Carvalho, F | 1 |
| Duarte, JA | 1 |
| Dunn, MJ | 1 |
| Pogorelov, VM | 1 |
| Lanthorn, TH | 1 |
| Savelieva, KV | 1 |
| Biala, G | 1 |
| Kruk, M | 1 |
| Rebec, GV | 1 |
| Bashore, TR | 1 |
| Solanto, MV | 1 |
| Schwartz, JM | 1 |
| Ksir, C | 2 |
| Koob, GF | 1 |
| Bloom, FE | 2 |
| Ellison, GD | 1 |
| Eison, MS | 1 |
| Benson, DM | 1 |
| MacLennan, AJ | 1 |
| Maier, SF | 1 |
| Swartzwelder, HS | 1 |
| Holahan, W | 1 |
| Myers, RD | 1 |
| Schlemmer, RF | 2 |
| Davis, JM | 2 |
| Thieme, RE | 1 |
| Dijkstra, H | 1 |
| Stoof, JC | 1 |
| King, GA | 1 |
| Burnham, WM | 1 |
| Cassens, G | 1 |
| Actor, C | 1 |
| Kling, M | 1 |
| Schildkraut, JJ | 1 |
| Thompson, T | 1 |
| Schechter, MD | 1 |
| Concannon, JT | 1 |
| Diamond, BI | 4 |
| Reyes, MG | 1 |
| Borison, R | 1 |
| Zenick, H | 1 |
| Goldsmith, M | 1 |
| Greer, CA | 1 |
| Alpern, HP | 1 |
| Erickson, CK | 1 |
| Olsson, M | 1 |
| Nikkhah, G | 1 |
| Bentlage, C | 1 |
| Björklund, A | 2 |
| Mook, DM | 1 |
| Neuringer, A | 1 |
| Lyon, M | 1 |
| McClure, WO | 1 |
| Wishart, TB | 1 |
| Ijaz, S | 1 |
| Shuaib, A | 1 |
| Mittleman, G | 1 |
| LeDuc, PA | 1 |
| Whishaw, IQ | 1 |
| Ellison, G | 3 |
| Switzer, RC | 1 |
| Kohlert, JG | 1 |
| Bloch, GJ | 1 |
| Lipska, BK | 1 |
| Jaskiw, GE | 1 |
| Weinberger, DR | 1 |
| Weiner, I | 1 |
| Shadach, E | 1 |
| Tarrasch, R | 1 |
| Kidron, R | 1 |
| Feldon, J | 1 |
| Segal, DS | 1 |
| Kuczenski, R | 1 |
| Sams-Dodd, F | 1 |
| Highfield, DA | 1 |
| Hu, D | 1 |
| Amsel, A | 1 |
| Jentsch, JD | 1 |
| Taylor, JR | 1 |
| Roth, RH | 1 |
| Russell, V | 1 |
| de Villiers, A | 1 |
| Sagvolden, T | 2 |
| Lamm, M | 1 |
| Taljaard, J | 1 |
| Borowski, TB | 1 |
| Kokkinidis, L | 1 |
| El-Khodor, BF | 1 |
| Boksa, P | 1 |
| Heyne, A | 1 |
| Wolffgramm, J | 1 |
| Wojcik, BE | 1 |
| Jinnah, HA | 1 |
| Muller-Sieburg, CE | 1 |
| Friedmann, T | 1 |
| Hebb, MO | 1 |
| Robertson, HA | 1 |
| Peacock, L | 1 |
| Gerlach, J | 1 |
| Watts, C | 1 |
| Brasted, PJ | 1 |
| Jiménez Vasquez, PA | 1 |
| Salmi, P | 1 |
| Ahlenius, S | 1 |
| Mathé, AA | 1 |
| Johnston, RE | 1 |
| Becker, JB | 1 |
| Waldner, R | 1 |
| Puschban, Z | 1 |
| Scherfler, C | 1 |
| Seppi, K | 1 |
| Jellinger, K | 1 |
| Poewe, W | 1 |
| Wenning, GK | 1 |
| Ruskin, DN | 1 |
| Bergstrom, DA | 1 |
| Shenker, A | 1 |
| Freeman, LE | 1 |
| Baek, D | 1 |
| Walters, JR | 1 |
| Mihm, MJ | 1 |
| Schanbacher, BL | 1 |
| Wallace, BL | 1 |
| Wallace, LJ | 1 |
| Uretsky, NJ | 1 |
| Bauer, JA | 1 |
| Harkin, A | 1 |
| Connor, TJ | 1 |
| Mulrooney, J | 1 |
| Kelly, JP | 1 |
| Leonard, BE | 1 |
| Vekovischeva, OY | 1 |
| Zamanillo, D | 1 |
| Echenko, O | 1 |
| Seppälä, T | 1 |
| Uusi-Oukari, M | 1 |
| Honkanen, A | 1 |
| Seeburg, PH | 1 |
| Sprengel, R | 1 |
| Korpi, ER | 1 |
| Bashkatova, V | 1 |
| Mathieu-Kia, AM | 1 |
| Durand, C | 1 |
| Penit-Soria, J | 1 |
| Mason, ST | 3 |
| Sanberg, PR | 3 |
| Fibiger, HC | 4 |
| Garver, DL | 1 |
| Maas, JW | 1 |
| Crossman, AR | 1 |
| Sambrook, MA | 1 |
| Bareggi, SR | 1 |
| Becker, RE | 1 |
| Ginsburg, B | 1 |
| Genovese, E | 1 |
| Lehmann, J | 1 |
| Borison, RL | 3 |
| Havdala, HS | 2 |
| Margolin, DI | 2 |
| Trabucchi, M | 1 |
| Albizzati, MG | 1 |
| Frattola, L | 1 |
| Scarlato, G | 1 |
| Suri, KB | 1 |
| Crampton, GH | 1 |
| Daunton, NG | 1 |
| Nausieda, PA | 3 |
| Koller, WC | 1 |
| Weiner, WJ | 3 |
| Klawans, HL | 4 |
| Campbell, BA | 1 |
| Randall, PJ | 1 |
| Flemenbaum, A | 2 |
| Trulson, ME | 1 |
| Jacobs, BL | 1 |
| Robinson, RG | 1 |
| Yehuda, S | 1 |
| Carasso, RL | 1 |
| Goetz, C | 1 |
| Altshuler, H | 1 |
| Weaver, S | 1 |
| Phillips, P | 1 |
| Gambill, JD | 1 |
| Kornetsky, C | 1 |
| David, J | 1 |
| Kaul, CL | 1 |
| Grewal, RS | 1 |
| Shaywitz, BA | 1 |
| Klopper, JH | 1 |
| Yager, RD | 1 |
| Gordon, JW | 1 |
| Costall, B | 1 |
| Naylor, RJ | 1 |
| Dana, N | 1 |
| Crosset, P | 1 |
| Kong, D | 1 |
| Metzger, MA | 1 |
| Schiørbeck, HK | 1 |
| Rugland, AL | 1 |
| Spinnangr, I | 1 |
| Sagvolden, G | 1 |
| Cheung, BS | 1 |
| Money, KE | 1 |
| Kohl, RL | 1 |
| Kinter, LB | 1 |
| Lipton, J | 1 |
| Zeigler, S | 1 |
| Wilkins, J | 1 |
| Cappeliez, P | 1 |
| Moore, E | 1 |
| Weinstein, D | 1 |
| See, RE | 1 |
| Archer, T | 1 |
| Fredriksson, A | 1 |
| Sundström, E | 1 |
| Luthman, J | 1 |
| Lewander, T | 1 |
| Söderberg, U | 1 |
| Jonsson, G | 1 |
| Treit, D | 1 |
| Fundytus, M | 1 |
| Brundin, P | 1 |
| Nilsson, OG | 1 |
| Strecker, RE | 1 |
| Lindvall, O | 1 |
| Astedt, B | 1 |
| Ando, K | 1 |
| Hironaka, N | 1 |
| Yanagita, T | 1 |
| Kato, S | 1 |
| Davies, C | 1 |
| Sanger, DJ | 1 |
| Steinberg, H | 1 |
| Tomkiewicz, M | 1 |
| U'Prichard, DC | 1 |
| Krsiak, M | 1 |
| Silbergeld, EK | 1 |
| Goldberg, AM | 1 |
| Salama, AI | 1 |
| Goldberg, ME | 1 |
| Nora, JJ | 1 |
| Sommerville, RJ | 1 |
| Fraser, FC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Differences in Voxel-based Morphometry of Different Brain Structures in Patients With Mood Disorder Bipolar Mania in Comparison to Morphometry of Nrmal Controls[NCT03181698] | 45 participants (Actual) | Observational | 2017-09-22 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 reviews available for dextroamphetamine and Disease Models, Animal
| Article | Year |
|---|---|
Pharmacological Enhancement of Stroke Rehabilitation.
Topics: Animals; Dextroamphetamine; Disease Models, Animal; Humans; Levodopa; Neuronal Plasticity; Randomize | 2019 |
The effects of amphetamine on recovery of function in animal models of cerebral injury: a critical appraisal.
Topics: Animals; Brain Injuries; Central Nervous System Stimulants; Dextroamphetamine; Disease Models, Anima | 2009 |
Behavioural and neurochemical abnormalities in mice lacking functional tachykinin-1 (NK1) receptors: a model of attention deficit hyperactivity disorder.
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Brain; Dextroamphetamine; Disease Models, An | 2009 |
The zebrafish as a model system for assessing the reinforcing properties of drugs of abuse.
Topics: Animals; Behavior, Addictive; Conditioning, Psychological; Dextroamphetamine; Disease Models, Animal | 2006 |
Neuropharmacological basis of stimulant drug action in attention deficit disorder with hyperactivity: a review and synthesis.
Topics: Animals; Attention; Attention Deficit Disorder with Hyperactivity; Brain Chemistry; Central Nervous | 1984 |
Behavioral mechanisms and loci of drug dependence: an overview.
Topics: Animals; Behavior; Compulsive Behavior; Dextroamphetamine; Disease Models, Animal; Humans; Motivatio | 1981 |
The hyperkinetic child syndrome and brain monoamines: pharmacology and therapeutic implications.
Topics: Animals; Arousal; Attention; Brain; Child; Dextroamphetamine; Disease Models, Animal; Dopamine; Huma | 1978 |
177 other studies available for dextroamphetamine and Disease Models, Animal
| Article | Year |
|---|---|
The Trace Amine 1 receptor knockout mouse: an animal model with relevance to schizophrenia.
Topics: Amphetamine; Animals; Anxiety; Behavior, Animal; Catecholamines; Central Nervous System Stimulants; | 2007 |
Topics: Animals; Base Composition; Clostridiales; Dextroamphetamine; Disease Models, Animal; Dopaminergic Ne | 2022 |
Coadministration of lithium and celecoxib reverses manic-like behavior and decreases oxidative stress in a dopaminergic model of mania induced in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antimanic Agents; Behavior, Animal; Bipolar Disord | 2019 |
Doxycycline reverses cognitive impairment, neuroinflammation and oxidative imbalance induced by D-amphetamine mania model in mice: A promising drug repurposing for bipolar disorder treatment?
Topics: Animals; Antimanic Agents; Bipolar Disorder; Cognitive Dysfunction; Dextroamphetamine; Disease Model | 2021 |
Influence of intertrial interval on basal and drug-induced impulsive action in the 5-choice serial reaction time task: Effects of d-amphetamine and (±)-2,5-dimethoxy-4-iodoamphetamine (DOI).
Topics: Amphetamines; Animals; Behavior, Animal; Central Nervous System Stimulants; Dextroamphetamine; Disea | 2018 |
Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against Glioblastoma.
Topics: Animals; Antibodies, Neoplasm; Antigens, CD19; Brain Neoplasms; Cytotoxicity, Immunologic; Dextroamp | 2018 |
Response-inhibition capacity in spontaneously hypertensive and Wistar rats: acquisition of fixed minimum interval performance and responsiveness to D-amphetamine.
Topics: Analysis of Variance; Animals; Attention Deficit Disorder with Hyperactivity; Central Nervous System | 2018 |
Characterization of locomotor response to psychostimulants in the parthenogenetic marbled crayfish (Procambarus fallax forma virginalis): A promising model for studying the neural and molecular mechanisms of drug addiction.
Topics: Animals; Astacoidea; Central Nervous System Stimulants; Dextroamphetamine; Disease Models, Animal; L | 2019 |
The role of neurotrophic factors in manic-, anxious- and depressive-like behaviors induced by amphetamine sensitization: Implications to the animal model of bipolar disorder.
Topics: Animals; Anxiety; Behavior, Animal; Bipolar Disorder; Brain; Brain-Derived Neurotrophic Factor; Corp | 2019 |
Coadministration of lithium and celecoxib attenuates the behavioral alterations and inflammatory processes induced by amphetamine in an animal model of mania.
Topics: Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antimanic Agents; Behavior, | 2019 |
Map2k7 Haploinsufficiency Induces Brain Imaging Endophenotypes and Behavioral Phenotypes Relevant to Schizophrenia.
Topics: Animals; Behavior, Animal; Brain; Connectome; Dextroamphetamine; Disease Models, Animal; Dopamine Up | 2020 |
Effect of co-treatment with mirtazapine and risperidone in animal models of the positive symptoms of schizophrenia in mice.
Topics: Amphetamines; Animals; Antipsychotic Agents; Behavior, Animal; Dextroamphetamine; Disease Models, An | 2012 |
The antipsychotic-like effects of the mGlu group III orthosteric agonist, LSP1-2111, involves 5-HT₁A signalling.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Aminobutyrates; Amphetamines; Animals; Antipsychotic Agents; | 2013 |
Chronic intranasal deferoxamine ameliorates motor defects and pathology in the α-synuclein rAAV Parkinson's model.
Topics: Administration, Intranasal; alpha-Synuclein; Animals; Antigens, CD; Antigens, Differentiation, Myelo | 2013 |
Opposite effects of neonatal hypoxia on acute amphetamine-induced hyperlocomotion in adult and adolescent mice.
Topics: Age Factors; Animals; Animals, Newborn; Dextroamphetamine; Disease Models, Animal; Hyperkinesis; Hyp | 2013 |
Attenuation of acute d-amphetamine-induced disruption of conflict resolution by clozapine, but not α-flupenthixol in rats.
Topics: Animals; Antipsychotic Agents; Central Nervous System Stimulants; Clozapine; Conditioning, Operant; | 2013 |
Impulsivity and motor activity in aged, male Ts65Dn mice.
Topics: Aging; Animals; Central Nervous System Stimulants; Conditioning, Operant; Dextroamphetamine; Disease | 2013 |
Amphetamine-induced appetitive 50-kHz calls in rats: a marker of affect in mania?
Topics: Animals; Antimanic Agents; Bipolar Disorder; Central Nervous System Stimulants; Dextroamphetamine; D | 2014 |
Enhanced visual responses in the superior colliculus in an animal model of attention-deficit hyperactivity disorder and their suppression by D-amphetamine.
Topics: Action Potentials; Animals; Attention Deficit Disorder with Hyperactivity; Central Nervous System Ag | 2014 |
Cognitive judgment bias in the psychostimulant-induced model of mania in rats.
Topics: Animals; Behavior, Animal; Bipolar Disorder; Cocaine; Dextroamphetamine; Disease Models, Animal; Dop | 2015 |
Novel tricyclic[2,1-f]theophylline derivatives of LCAP with activity in mouse models of affective disorders.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Dextroamphetamine; Disease Models, Animal; Male; Me | 2014 |
Role of P2X7 Receptor in an Animal Model of Mania Induced by D-Amphetamine.
Topics: Animals; Bipolar Disorder; Brain; Dextroamphetamine; Disease Models, Animal; Inflammation Mediators; | 2016 |
Lithium modulates the production of peripheral and cerebral cytokines in an animal model of mania induced by dextroamphetamine.
Topics: Animals; Antimanic Agents; Behavior, Animal; Bipolar Disorder; Brain; Central Nervous System Stimula | 2015 |
Amphetamine sensitization in mice is sufficient to produce both manic- and depressive-related behaviors as well as changes in the functional connectivity of corticolimbic structures.
Topics: Anhedonia; Animals; Bipolar Disorder; Cerebral Cortex; Dextroamphetamine; Disease Models, Animal; Li | 2015 |
D-Amphetamine withdrawal-induced decreases in brain-derived neurotrophic factor in sprague-dawley rats are reversed by treatment with ketamine.
Topics: Amphetamine-Related Disorders; Animals; Brain-Derived Neurotrophic Factor; Central Nervous System St | 2015 |
Methodology and effects of repeated intranasal delivery of DNSP-11 in a rat model of Parkinson's disease.
Topics: Administration, Intranasal; Analysis of Variance; Animals; Antiparkinson Agents; Autoradiography; Co | 2015 |
Mice heterozygous for cathepsin D deficiency exhibit mania-related behavior and stress-induced depression.
Topics: Adaptation, Ocular; Animals; Antidepressive Agents; Bipolar Disorder; Cathepsin D; Corticosterone; D | 2015 |
BDNF-Deficient Mice Show Reduced Psychosis-Related Behaviors Following Chronic Methamphetamine.
Topics: Amphetamine-Related Disorders; Animals; Brain-Derived Neurotrophic Factor; Central Nervous System St | 2016 |
Methamphetamine-, d-Amphetamine-, and p-Chloroamphetamine-Induced Neurotoxicity Differentially Effect Impulsive Responding on the Stop-Signal Task in Rats.
Topics: Animals; Body Temperature; Brain; Central Nervous System Stimulants; Dextroamphetamine; Disease Mode | 2016 |
Genetic blockade of adenosine A2A receptors induces cognitive impairments and anatomical changes related to psychotic symptoms in mice.
Topics: Animals; Brain; Brain-Derived Neurotrophic Factor; Cognitive Dysfunction; Dextroamphetamine; Disease | 2016 |
The Combination of Scopolamine and Psychostimulants for the Prevention of Severe Motion Sickness.
Topics: Analysis of Variance; Animals; Benzhydryl Compounds; Caffeine; Central Nervous System Stimulants; Ch | 2016 |
The Effects of Histone Deacetylase Inhibition on the Levels of Cerebral Cytokines in an Animal Model of Mania Induced by Dextroamphetamine.
Topics: Animals; Antimanic Agents; Bipolar Disorder; Brain; Cytokines; Dextroamphetamine; Disease Models, An | 2018 |
Pramipexole restores depressed transmission in the ventral hippocampus following MPTP-lesion.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Benzothiazoles; Dextroamphetamine; Disease Mo | 2017 |
Poststroke treatment: lost in translation.
Topics: Age Factors; Animals; Brain; Central Nervous System Stimulants; Clinical Protocols; Clinical Trials | 2009 |
Schizophrenia model of elevated D2(High) receptors: haloperidol reverses the amphetamine-induced elevation in dopamine D2(High).
Topics: Animals; Antipsychotic Agents; Corpus Striatum; Dextroamphetamine; Disease Models, Animal; Dopamine | 2009 |
Olanzapine and risperidone disrupt conditioned avoidance responding in phencyclidine-pretreated or amphetamine-pretreated rats by selectively weakening motivational salience of conditioned stimulus.
Topics: Animals; Antipsychotic Agents; Avoidance Learning; Behavior, Animal; Benzodiazepines; Conditioning, | 2009 |
The GABA-B antagonist 2-hydroxysaclofen reverses the effects of baclofen on the discriminative stimulus effects of D-amphetamine in the conditioned taste aversion procedure.
Topics: Animals; Baclofen; Central Nervous System Stimulants; Conditioning, Psychological; Dextroamphetamine | 2009 |
Specificity of direct transition from wake to REM sleep in orexin/ataxin-3 transgenic narcoleptic mice.
Topics: Analysis of Variance; Animals; Antidepressive Agents, Tricyclic; Ataxin-3; Benzhydryl Compounds; Cen | 2009 |
The d-amphetamine-treated Göttingen miniature pig: an animal model for assessing behavioral effects of antipsychotics.
Topics: Animals; Antipsychotic Agents; Dextroamphetamine; Disease Models, Animal; Dose-Response Relationship | 2009 |
Schizophrenia-relevant behaviours in a genetic mouse model for Y2 deficiency.
Topics: Animals; Behavior, Animal; Cognition; Dextroamphetamine; Disease Models, Animal; Dizocilpine Maleate | 2010 |
GBR 12909 administration as a mouse model of bipolar disorder mania: mimicking quantitative assessment of manic behavior.
Topics: Animals; Behavior, Animal; Bipolar Disorder; Dextroamphetamine; Disease Models, Animal; Dopamine Pla | 2010 |
Efficacy of the atypical antipsychotic aripiprazole in d-amphetamine-based preclinical models of mania.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Central Nervous System Stimulants; De | 2010 |
Acoustic startle response and sensorimotor gating in a genetic mouse model for the Y1 receptor.
Topics: Animals; Dextroamphetamine; Disease Models, Animal; Dizocilpine Maleate; Humans; Male; Mice; Mice, K | 2010 |
Effects of mood stabilizers on mitochondrial respiratory chain activity in brain of rats treated with d-amphetamine.
Topics: Animals; Antimanic Agents; Bipolar Disorder; Brain; Corpus Striatum; Dextroamphetamine; Disease Mode | 2010 |
Mice lacking p35 display hyperactivity and paradoxical response to psychostimulants.
Topics: Animals; Central Nervous System Stimulants; Corpus Striatum; Cyclin-Dependent Kinase 5; Dextroamphet | 2010 |
Long-term histological and behavioural characterisation of a collagenase-induced model of intracerebral haemorrhage in rats.
Topics: Animals; Brain; Cerebral Arteries; Cerebral Hemorrhage; Collagenases; Dextroamphetamine; Disability | 2010 |
Mood disorder susceptibility gene CACNA1C modifies mood-related behaviors in mice and interacts with sex to influence behavior in mice and diagnosis in humans.
Topics: Animals; Behavior, Animal; Calcium Channels, L-Type; Dextroamphetamine; Disease Models, Animal; Fema | 2010 |
Prolonged attenuation of the reinforcing strength of cocaine by chronic d-amphetamine in rhesus monkeys.
Topics: Animals; Cocaine; Cocaine-Related Disorders; Dextroamphetamine; Disease Models, Animal; Dopamine Upt | 2011 |
Tamoxifen effects on respiratory chain complexes and creatine kinase activities in an animal model of mania.
Topics: Animals; Antimanic Agents; Bipolar Disorder; Brain; Creatine Kinase; Dextroamphetamine; Disease Mode | 2011 |
Group II mGluR agonist LY354740 and NAAG peptidase inhibitor effects on prepulse inhibition in PCP and D-amphetamine models of schizophrenia.
Topics: Animals; Bridged Bicyclo Compounds; Dextroamphetamine; Disease Models, Animal; Dose-Response Relatio | 2011 |
N-acetyl cysteine restores brain glutathione loss in combined 2-cyclohexene-1-one and d-amphetamine-treated rats: relevance to schizophrenia and bipolar disorder.
Topics: Acetylcysteine; Animals; Bipolar Disorder; Brain; Corpus Striatum; Cyclohexanones; Dextroamphetamine | 2011 |
Early life stress decreases hippocampal BDNF content and exacerbates recognition memory deficits induced by repeated D-amphetamine exposure.
Topics: Analysis of Variance; Animals; Animals, Newborn; Brain-Derived Neurotrophic Factor; Central Nervous | 2011 |
Differences between dextroamphetamine and methamphetamine: behavioral changes and oxidative damage in brain of Wistar rats.
Topics: Animals; Brain; Central Nervous System Stimulants; Dextroamphetamine; Disease Models, Animal; Dose-R | 2012 |
Pharmacological evaluation of the adequacy of marble burying as an animal model of compulsion and/or anxiety.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Anxiety Disorders; Behavior, Animal; Benzothiazoles; Carbolin | 2011 |
Opposing efficacy of group III mGlu receptor activators, LSP1-2111 and AMN082, in animal models of positive symptoms of schizophrenia.
Topics: Aminobutyrates; Amphetamines; Animals; Antipsychotic Agents; Benzhydryl Compounds; Dextroamphetamine | 2012 |
Behavioral and neurochemical effects of sodium butyrate in an animal model of mania.
Topics: Animals; Antimanic Agents; Behavior, Animal; Bipolar Disorder; Brain; Butyric Acid; Central Nervous | 2011 |
Striking differences in proconvulsant-induced alterations of seizure threshold in two rat models.
Topics: Animals; Anticonvulsants; Caffeine; Central Nervous System Stimulants; Chlorpromazine; Convulsants; | 2012 |
Effects of sertraline on experimental mouse models of psychosis.
Topics: Animals; Antidepressive Agents; Apomorphine; Catalepsy; Dextroamphetamine; Disease Models, Animal; D | 2012 |
Protein kinase C and oxidative stress in an animal model of mania.
Topics: Animals; Antimanic Agents; Behavior, Animal; Bipolar Disorder; Brain; Dextroamphetamine; Disease Mod | 2012 |
Early prefrontal functional blockade in rats results in schizophrenia-related anomalies in behavior and dopamine.
Topics: Animals; Animals, Newborn; Dextroamphetamine; Disease Models, Animal; Dopamine; Dopamine Uptake Inhi | 2012 |
Human albumin prevents 6-hydroxydopamine-induced loss of tyrosine hydroxylase in in vitro and in vivo.
Topics: Albumins; Animals; Caspase 3; Cell Line, Tumor; Dextroamphetamine; Disease Models, Animal; Dopaminer | 2012 |
NAAG peptidase inhibitors block cognitive deficit induced by MK-801 and motor activation induced by d-amphetamine in animal models of schizophrenia.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Dextroamphetamine; Disease Models, Animal; Dose | 2012 |
Effects of alpha-lipoic acid in an animal model of mania induced by D-amphetamine.
Topics: Animals; Antimanic Agents; Bipolar Disorder; Brain; Brain-Derived Neurotrophic Factor; Central Nervo | 2012 |
Influence of stimulant-induced hyperactivity on social approach in the BTBR mouse model of autism.
Topics: Animals; Autistic Disorder; Behavior, Animal; Dextroamphetamine; Disease Models, Animal; Dose-Respon | 2013 |
Enhanced reward-facilitating effects of d-amphetamine in rats in the quinpirole model of obsessive-compulsive disorder.
Topics: Analysis of Variance; Animals; Central Nervous System Stimulants; Conditioning, Operant; Dextroamphe | 2013 |
Lithium and tamoxifen modulate cellular plasticity cascades in animal model of mania.
Topics: Animals; Antimanic Agents; Apoptosis; Behavior, Animal; Bipolar Disorder; Blotting, Western; Dextroa | 2012 |
Evaluation of acetylcholinesterase in an animal model of mania induced by D-amphetamine.
Topics: Acetylcholinesterase; Analysis of Variance; Animals; Antimanic Agents; Bipolar Disorder; Brain; Cent | 2013 |
Assessment of behaviors modeling aspects of schizophrenia in Csmd1 mutant mice.
Topics: Alleles; Animals; Behavior, Animal; Dextroamphetamine; Disease Models, Animal; Exons; Female; Food P | 2012 |
[Comparison between two anti-motion sickness drugs].
Topics: Animals; Antiemetics; Central Nervous System Stimulants; Cyclizine; Dextroamphetamine; Disease Model | 1999 |
Validation of a modified mirrored chamber sensitive to anxiolytics and anxiogenics in mice.
Topics: Animals; Animals, Outbred Strains; Anti-Anxiety Agents; Anxiety; Carbolines; Dextroamphetamine; Diaz | 2003 |
The role of pretraining on skilled forelimb use in an animal model of Huntington's disease.
Topics: Animals; Corpus Striatum; Dextroamphetamine; Disease Models, Animal; Dopamine Agents; Female; Foreli | 2003 |
Impaired DRL 30 performance during amphetamine withdrawal.
Topics: Animals; Central Nervous System Stimulants; Conditioning, Operant; Dextroamphetamine; Disease Models | 2003 |
Atypical antipsychotic profile of flunarizine in animal models.
Topics: Administration, Oral; Animals; Catalepsy; Dextroamphetamine; Disease Models, Animal; Dizocilpine Mal | 2005 |
Co-transplantation of carotid body and ventral mesencephalic cells as an alternative approach towards functional restoration in 6-hydroxydopamine-lesioned rats: implications for Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Binding, Competitive; Brain Tissue Transplantation; Carotid | 2004 |
D-Amphetamine reinstates behavior previously maintained by food: importance of context.
Topics: Animals; Appetitive Behavior; Central Nervous System Stimulants; Conditioning, Classical; Dextroamph | 2004 |
Evaluation of the reinforcing effects of monoamine reuptake inhibitors under a concurrent schedule of food and i.v. drug delivery in rhesus monkeys.
Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hy | 2005 |
D-Amphetamine remediates attentional performance in rats with dorsal prefrontal lesions.
Topics: Animals; Attention; Behavior, Animal; Brain Injuries; Central Nervous System Stimulants; Conditionin | 2005 |
Evaluation of the effects of lamotrigine, valproate and carbamazepine in a rodent model of mania.
Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Bipolar Disorder; Carbamazepine; Central Nervous Syst | 2005 |
SSR181507, a dopamine D(2) receptor antagonist and 5-HT(1A) receptor agonist, alleviates disturbances of novelty discrimination in a social context in rats, a putative model of selective attention deficit.
Topics: Age Factors; Animals; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Clozapine; De | 2005 |
D-amphetamine enhances skilled reaching after ischemic cortical lesions in rats.
Topics: Animals; Brain Ischemia; Central Nervous System Stimulants; Cerebral Infarction; Denervation; Dextro | 2005 |
D-amphetamine improves cognitive deficits and physical therapy promotes fine motor rehabilitation in a rat embolic stroke model.
Topics: Animals; Central Nervous System Stimulants; Cognition Disorders; Dextroamphetamine; Disease Models, | 2006 |
Genetic identification of AChE as a positive modulator of addiction to the psychostimulant D-amphetamine in zebrafish.
Topics: Acetylcholine; Acetylcholinesterase; Amphetamine-Related Disorders; Animals; Biological Evolution; B | 2006 |
CP-809,101, a selective 5-HT2C agonist, shows activity in animal models of antipsychotic activity.
Topics: Amphetamines; Animals; Antipsychotic Agents; Avoidance Learning; Behavior, Animal; Catalepsy; Dextro | 2007 |
Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania.
Topics: Animals; Anticonvulsants; Antimanic Agents; Bipolar Disorder; Catalase; Dextroamphetamine; Disease M | 2006 |
A single injection of D-amphetamine facilitates improvements in motor training following a focal cortical infarct in squirrel monkeys.
Topics: Animals; Brain Ischemia; Central Nervous System Stimulants; Cerebral Arteries; Cerebral Infarction; | 2006 |
Reduction of impulsivity with amphetamine in an appetitive fixed consecutive number schedule with cue for optimal performance in rats.
Topics: Animals; Appetitive Behavior; Central Nervous System Stimulants; Conditioning, Operant; Cues; Dextro | 2007 |
Effect of physical exercise on markers of acute cardiotoxicity induced by d-amphetamine in an animal model.
Topics: Acute Disease; Animals; Biomarkers; Body Temperature; Central Nervous System Stimulants; Dextroamphe | 2006 |
Medial prefrontal cortex infusion of alpha-flupenthixol attenuates systemic d-amphetamine-induced disruption of conditional discrimination performance in rats.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Central Nervous System Stimulants; Conditioning, Op | 2007 |
Use of a platform in an automated open-field to enhance assessment of anxiety-like behaviors in mice.
Topics: Animals; Anxiety; Automation; Crosses, Genetic; Darkness; Dextroamphetamine; Disease Models, Animal; | 2007 |
Calcium channel antagonists suppress cross-tolerance to the anxiogenic effects of D-amphetamine and nicotine in the mouse elevated plus maze test.
Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Calcium Channel Block | 2008 |
Critical issues in assessing the behavioral effects of amphetamine.
Topics: Amphetamine; Animals; Antipsychotic Agents; Arousal; Behavior, Animal; Brain; Dextroamphetamine; Dis | 1984 |
Changes in locomotor response to beta-endorphin microinfusion during and after opiate abstinence syndrome--a proposal for a model of the onset of mania.
Topics: Affective Disorders, Psychotic; Animals; beta-Endorphin; Bipolar Disorder; Dextroamphetamine; Diseas | 1982 |
Continuous amphetamine intoxication: an animal model of the acute psychotic episode.
Topics: Animals; Behavior, Animal; Caudate Nucleus; Dextroamphetamine; Disease Models, Animal; Dopamine; Hal | 1983 |
Enhanced behavioral response to nicotine in an animal model of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Dextroamphetamine; Disease Models, Animal; Humans; Kainic Acid; Male; Mo | 1983 |
Coping and the stress-induced potentiation of stimulant stereotypy in the rat.
Topics: Animals; Cocaine; Dextroamphetamine; Disease Models, Animal; Drug Synergism; Humans; Rats; Schizophr | 1983 |
Antagonism by d-amphetamine of trimethyltin-induced hyperactivity evidence toward an animal model of hyperkinetic behavior.
Topics: Animals; Dextroamphetamine; Disease Models, Animal; Humans; Hyperkinesis; Male; Motor Activity; Rats | 1983 |
A comparison of three psychotomimetic-induced models of psychosis in nonhuman primate social colonies.
Topics: Animals; Dextroamphetamine; Disease Models, Animal; Female; Hallucinogens; Humans; Macaca; Phencycli | 1983 |
An evaluation of the young dopamine-lesioned rat as an animal model for minimal brain dysfunction (MBD).
Topics: Animals; Apomorphine; Attention; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; De | 1980 |
Effects of d-amphetamine and apomorphine in a new animal model of petit mal epilepsy.
Topics: Animals; Apomorphine; Dextroamphetamine; Disease Models, Animal; Dose-Response Relationship, Drug; D | 1980 |
Amphetamine withdrawal: effects on threshold of intracranial reinforcement.
Topics: Animals; Behavior, Animal; Depression; Dextroamphetamine; Disease Models, Animal; Humans; Male; Rats | 1981 |
Haloperidol-induced hyperactivity in neonatal rats: effect of lithium and stimulants.
Topics: Animals; Animals, Newborn; Dextroamphetamine; Disease Models, Animal; Female; Haloperidol; Humans; H | 1982 |
A new animal model for Tourette syndrome.
Topics: Animals; Apomorphine; Dextroamphetamine; Disease Models, Animal; Haloperidol; Humans; Male; Nitriles | 1982 |
Drug discrimination learning in lead-exposed rats.
Topics: Animals; Behavior, Animal; Dextroamphetamine; Discrimination Learning; Disease Models, Animal; Femal | 1981 |
Paradoxical effects of d-amphetamine upon seizure susceptibility in 2 selectively bred lines of mice.
Topics: Age Factors; Animals; Anticonvulsants; Convulsants; Dextroamphetamine; Disease Models, Animal; Dopam | 1980 |
Requirements for an ideal alcohol antagonist.
Topics: Alcoholic Intoxication; Animals; Caffeine; Cats; Dextroamphetamine; Disease Models, Animal; Dogs; Et | 1980 |
Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Analysis of Variance; Animals; Apomorphi | 1995 |
Different effects of amphetamine on reinforced variations versus repetitions in spontaneously hypertensive rats (SHR).
Topics: Animals; Arousal; Attention Deficit Disorder with Hyperactivity; Conditioning, Operant; Dextroamphet | 1994 |
Investigations of fetal development models for prenatal drug exposure and schizophrenia. Prenatal d-amphetamine effects upon early and late juvenile behavior in the rat.
Topics: Animals; Behavior, Animal; Body Weight; Catalepsy; Dextroamphetamine; Disease Models, Animal; Extinc | 1994 |
Differential effects of amphetamine and haloperidol on recovery after global forebrain ischemia.
Topics: Animals; Brain Ischemia; Dextroamphetamine; Disease Models, Animal; Gerbillinae; Haloperidol; Male; | 1994 |
The role of D1 and D2 receptors in the heightened locomotion induced by direct and indirect dopamine agonists in rats with hippocampal damage: an animal analogue of schizophrenia.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Arousal; Brain Map | 1993 |
Dissimilar patterns of degeneration in brain following four different addictive stimulants.
Topics: Animals; Brain; Cocaine; Dextroamphetamine; Disease Models, Animal; Drug Implants; Methamphetamine; | 1993 |
A rat model for attention deficit-hyperactivity disorder.
Topics: Animals; Attention; Attention Deficit Disorder with Hyperactivity; Avoidance Learning; Dextroampheta | 1993 |
Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of schizophrenia.
Topics: Animals; Animals, Newborn; Dextroamphetamine; Disease Models, Animal; Female; Haloperidol; Hippocamp | 1993 |
The latent inhibition model of schizophrenia: further validation using the atypical neuroleptic, clozapine.
Topics: Animals; Antipsychotic Agents; Association Learning; Attention; Clozapine; Conditioning, Classical; | 1996 |
An escalating dose "binge" model of amphetamine psychosis: behavioral and neurochemical characteristics.
Topics: Animals; Brain; Caudate Nucleus; Dextroamphetamine; Disease Models, Animal; Dopamine; Dose-Response | 1997 |
A test of the predictive validity of animal models of schizophrenia based on phencyclidine and D-amphetamine.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Clozapine; Dextroamphetamine; Disease Models, Anima | 1998 |
Alleviation of x-irradiation-based deficit in memory-based learning by D-amphetamine: suggestions for attention deficit-hyperactivity disorder.
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Dextroamp | 1998 |
Subchronic phencyclidine administration increases mesolimbic dopaminergic system responsivity and augments stress- and psychostimulant-induced hyperlocomotion.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Brain; Dextroamphetamine; Disease Mod | 1998 |
Differences between electrically-, ritalin- and D-amphetamine-stimulated release of [3H]dopamine from brain slices suggest impaired vesicular storage of dopamine in an animal model of Attention-Deficit Hyperactivity Disorder.
Topics: Animals; Brain; Brain Mapping; Central Nervous System Stimulants; Culture Techniques; Dextroamphetam | 1998 |
The effects of cocaine, amphetamine, and the dopamine D1 receptor agonist SKF 38393 on fear extinction as measured with potentiated startle: implications for psychomotor stimulant psychosis.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Acoustic Stimulation; Analysis of Varian | 1998 |
Birth insult increases amphetamine-induced behavioral responses in the adult rat.
Topics: Animals; Behavior, Animal; Birth Injuries; Cesarean Section; Dextroamphetamine; Disease Models, Anim | 1998 |
The development of addiction to d-amphetamine in an animal model: same principles as for alcohol and opiate.
Topics: Animals; Behavior, Animal; Central Nervous System Depressants; Central Nervous System Stimulants; De | 1998 |
Bone marrow transplantation does not ameliorate the neurologic symptoms in mice deficient in hypoxanthine guanine phosphoribosyl transferase (HPRT).
Topics: Animals; Behavior, Animal; Bone Marrow Transplantation; Dextroamphetamine; Disease Models, Animal; D | 1999 |
Motor effects and mapping of cerebral alterations in animal models of Parkinson's and Huntington's diseases.
Topics: Animals; Behavior, Animal; Brain; Brain Mapping; Corpus Striatum; Dextroamphetamine; Disease Models, | 1999 |
New and old antipsychotics versus clozapine in a monkey model: adverse effects and antiamphetamine effects.
Topics: Amphetamine; Animals; Antipsychotic Agents; Cebus; Clozapine; Dextroamphetamine; Disease Models, Ani | 1999 |
Embryonic donor age and dissection influences striatal graft development and functional integration in a rodent model of Huntington's disease.
Topics: Acetylcholinesterase; Animals; Brain Tissue Transplantation; Cell Count; Cell Differentiation; Cell | 2000 |
Neuropeptide Y in brains of the Flinders Sensitive Line rat, a model of depression. Effects of electroconvulsive stimuli and d-amphetamine on peptide concentrations and locomotion.
Topics: Animals; Depression; Dextroamphetamine; Disease Models, Animal; Dopamine; Electroconvulsive Therapy; | 2000 |
Behavioral changes associated with grafts of embryonic ventral mesencephalon tissue into the striatum and/or substantia nigra in a rat model of Parkinson's Disease.
Topics: Analysis of Variance; Animals; Behavior, Animal; Brain Tissue Transplantation; Corpus Striatum; Dext | 1999 |
No functional effects of embryonic neuronal grafts on motor deficits in a 3-nitropropionic acid rat model of advanced striatonigral degeneration (multiple system atrophy).
Topics: Animals; Apomorphine; Brain Tissue Transplantation; Corpus Striatum; Dextroamphetamine; Disease Mode | 2001 |
Drugs used in the treatment of attention-deficit/hyperactivity disorder affect postsynaptic firing rate and oscillation without preferential dopamine autoreceptor action.
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Autoreceptors; Catecholamines; Central Nervo | 2001 |
Free 3-nitrotyrosine causes striatal neurodegeneration in vivo.
Topics: Animals; Cell Count; Corpus Striatum; Dextroamphetamine; Disease Models, Animal; Immunohistochemistr | 2001 |
Prior exposure to methylenedioxyamphetamine (MDA) induces serotonergic loss and changes in spontaneous exploratory and amphetamine-induced behaviors in rats.
Topics: Animals; Brain; Dextroamphetamine; Disease Models, Animal; Exploratory Behavior; Hallucinogens; Inje | 2001 |
Morphine-induced dependence and sensitization are altered in mice deficient in AMPA-type glutamate receptor-A subunits.
Topics: Acute Disease; Animals; Behavior, Animal; Brain; Calcium; Chronic Disease; Dextroamphetamine; Diseas | 2001 |
Neurochemical changes and neurotoxic effects of an acute treatment with sydnocarb, a novel psychostimulant: comparison with D-amphetamine.
Topics: Animals; Central Nervous System Stimulants; Corpus Striatum; Dextroamphetamine; Disease Models, Anim | 2002 |
Amphetamine-induced locomotor activity and stereotypy after kainic acid lesions of the striatum.
Topics: Animals; Behavior; Choline O-Acetyltransferase; Corpus Striatum; Dextroamphetamine; Disease Models, | 1978 |
Kainic acid lesions of the striatum dissociate amphetamine and apomorphine stereotypy: similarities to Huntingdon's chorea.
Topics: Animals; Apomorphine; Behavior; Choline O-Acetyltransferase; Corpus Striatum; Dextroamphetamine; Dis | 1978 |
Kainic acid lesions of the striatum: behavioural sequalae similar to Huntington's chorea.
Topics: Animals; Apomorphine; Cerebral Cortex; Choline O-Acetyltransferase; Corpus Striatum; Dextroamphetami | 1978 |
A schizophreniform behavioral psychosis mediated by dopamine.
Topics: Animals; Antipsychotic Agents; Dextroamphetamine; Disease Models, Animal; Macaca; Receptors, Dopamin | 1975 |
Experimental torticollis in the monkey produced by unilateral 6-hydroxy-dopamine brain lesions.
Topics: Animals; Apomorphine; Callitrichinae; Corpus Striatum; Dextroamphetamine; Disease Models, Animal; Do | 1978 |
Paradoxical effect of amphetamine in an endogenous model of the hyperkinetic syndrome in a hybrid dog: correlation with amphetamine and p-hydroxyamphetamine blood levels.
Topics: Amphetamine; Amphetamines; Animals; Behavior, Animal; Body Temperature; Dextroamphetamine; Disease M | 1979 |
Sedative effects of apomorphine in an animal model of Huntington's disease.
Topics: Animals; Apomorphine; Corpus Striatum; Dextroamphetamine; Disease Models, Animal; Humans; Huntington | 1979 |
A new animal model for schizophrenia: interactions with adrenergic mechanisms.
Topics: Animals; Behavior, Animal; Dextroamphetamine; Disease Models, Animal; Ditiocarb; Drug Antagonism; Dr | 1978 |
A new animal model for schizophrenia: cholinergic and serotonergic modulation.
Topics: 5-Hydroxytryptophan; Animals; Behavior, Animal; Dextroamphetamine; Disease Models, Animal; Dose-Resp | 1978 |
Hemiparkinsonism. A human model for studying dopaminergic supersensitivity.
Topics: Animals; Antiparkinson Agents; Bromocriptine; Carbidopa; Dextroamphetamine; Disease Models, Animal; | 1979 |
Motion sickness in cats: a symptom rating scale used in laboratory and flight tests.
Topics: Aerospace Medicine; Animals; Cats; Dextroamphetamine; Disease Models, Animal; Motion Sickness; Scopo | 1979 |
Clinical and experimental studies of phenytoin-induced hyperkinesias.
Topics: Aged; Animals; Apomorphine; Basal Ganglia; Corpus Striatum; Dextroamphetamine; Disease Models, Anima | 1979 |
Paradoxical effects of amphetamine on preweanling and postweanling rats.
Topics: Age Factors; Animals; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Dextroampheta | 1977 |
Chronic phenylethylamine stereotypy in rats: a new animal model for schizophrenia?
Topics: Animals; Behavior; Dextroamphetamine; Disease Models, Animal; Haloperidol; Humans; Male; Phenethylam | 1977 |
Dopamine receptors hypersensitivity: further confirmation following drug abuse model.
Topics: Amphetamine; Amphetamines; Animals; Dextroamphetamine; Disease Models, Animal; Drug Administration S | 1977 |
The effect of lithium on an animal model of tardive dyskinesia.
Topics: Animals; Apomorphine; Dextroamphetamine; Disease Models, Animal; Dyskinesia, Drug-Induced; Guinea Pi | 1977 |
Postsynaptic supersensitivity and kindling: further evidence of similarities.
Topics: Animals; Apomorphine; Behavior; Cocaine; Dextroamphetamine; Disease Models, Animal; Humans; Injectio | 1978 |
Long-term amphetamine treatment decreases brain serotonin metabolism: implications for theories of schizophrenia.
Topics: Animals; Behavior, Animal; Brain; Brain Chemistry; Cats; Dextroamphetamine; Disease Models, Animal; | 1979 |
Pharmacological treatment following experimental cerebral infarction: implications for understanding psychological symptoms of human stroke.
Topics: Animals; Brain; Desipramine; Dextroamphetamine; Disease Models, Animal; Hydroxydopamines; Intracrani | 1977 |
The effects of d-amphetamine and temperature on p-cresol and pentylenetetrazol induced convulsions.
Topics: Animals; Body Weight; Cresols; Dextroamphetamine; Disease Models, Animal; Dose-Response Relationship | 1977 |
Levodopa-induced dopamine receptor hypersensitivity.
Topics: Animals; Apomorphine; Dextroamphetamine; Disease Models, Animal; Dyskinesia, Drug-Induced; Humans; L | 1977 |
Intragastric self-administration of psychoactive drugs by the rhesus monkey.
Topics: Animals; Dextroamphetamine; Disease Models, Animal; Ethanol; Haplorhini; Humans; Macaca mulatta; Met | 1975 |
Effects of chronic d-amphetamine on social behavior of the rat: implications for an animal model of paranoid schizophrenia.
Topics: Animals; Dextroamphetamine; Disease Models, Animal; Humans; Rats; Schizophrenia, Paranoid; Schizophr | 1976 |
Effect of intracaudate drug injections on the striatal syndrome in reserpinized cats.
Topics: Animals; Apomorphine; Atropine; Cats; Caudate Nucleus; Corpus Striatum; Dextroamphetamine; Disease M | 1977 |
Paradoxical response to amphetamine in developing rats treated with 6-hydroxydopamine.
Topics: Age Factors; Animals; Attention Deficit Disorder with Hyperactivity; Brain; Cognition; Corpus Striat | 1976 |
Actions of dopaminergic agonists on motor function.
Topics: Amantadine; Animals; Apomorphine; Behavior; Dextroamphetamine; Disease Models, Animal; Dopamine Anta | 1975 |
Supersensitivity to d-amphetamine- and apomorphine-induced stereotyped behavior induced by chronic d-amphetamine administration.
Topics: Animals; Apomorphine; Behavior; Corpus Striatum; Dextroamphetamine; Disease Models, Animal; Dopamine | 1975 |
[Preliminary study of changes in plasma prostaglandin E1 in rats with experimental "schizophrenia"].
Topics: Alprostadil; Animals; Chlorpromazine; Dextroamphetamine; Disease Models, Animal; Female; Male; Rats; | 1992 |
The spontaneously hypertensive rat (SHR) as an animal model of childhood hyperactivity (ADHD): changed reactivity to reinforcers and to psychomotor stimulants.
Topics: Analysis of Variance; Animals; Attention Deficit Disorder with Hyperactivity; Central Nervous System | 1992 |
Investigation of anti-motion sickness drugs in the squirrel monkey.
Topics: Animals; Dextroamphetamine; Disease Models, Animal; Drug Therapy, Combination; Ephedrine; Male; Moti | 1992 |
A silicone pellet for continuous cocaine: comparison with continuous amphetamine.
Topics: Animals; Behavior, Animal; Cocaine; Dextroamphetamine; Disease Models, Animal; Drug Implants; Male; | 1991 |
Effects of lithium on an amphetamine animal model of bipolar disorder.
Topics: Animals; Bipolar Disorder; Chlorides; Dextroamphetamine; Disease Models, Animal; Lithium; Lithium Ch | 1990 |
Delayed appearance of facial tics following chronic fluphenazine administration to guinea pigs.
Topics: Animals; Dextroamphetamine; Disease Models, Animal; Dose-Response Relationship, Drug; Dyskinesia, Dr | 1989 |
Prenatal methylazoxymethanol treatment potentiates d-amphetamine- and methylphenidate-induced motor activity in male and female rats.
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Azo Compounds; Dextroamphetamine; Disease Mo | 1988 |
Thigmotaxis as a test for anxiolytic activity in rats.
Topics: Animals; Anxiety; Behavior, Animal; Dextroamphetamine; Disease Models, Animal; Male; Morphine; Motor | 1988 |
Behavioural effects of human fetal dopamine neurons grafted in a rat model of Parkinson's disease.
Topics: Animals; Catecholamines; Dextroamphetamine; Disease Models, Animal; Dopamine; Female; Fluorescent An | 1986 |
Psychotic manifestations in amphetamine abuse--experimental study on the mechanism of psychotic recurrence.
Topics: Animals; Conditioning, Operant; Dextroamphetamine; Disease Models, Animal; Male; Methamphetamine; Mi | 1986 |
[Behavioral changes in rhesus monkeys induced by repeated administration of ephedrine].
Topics: Animals; Behavior, Animal; Dextroamphetamine; Disease Models, Animal; Ephedrine; Humans; Macaca mula | 1985 |
Lithium and alpha-methyl-p-tyrosine prevent "manic" activity in rodents.
Topics: Animals; Bipolar Disorder; Chlordiazepoxide; Dextroamphetamine; Disease Models, Animal; Drug Combina | 1974 |
Proceedings: Isolation-induced timidity in mice as a measure of anxiolytic activity of drugs.
Topics: Animals; Anxiety Disorders; Barbiturates; Chlordiazepoxide; Chlorpromazine; Dextroamphetamine; Diaze | 1974 |
Lead-induced behavioral dysfunction: an animal model of hyperactivity.
Topics: Amphetamine; Animals; Chloral Hydrate; Dextroamphetamine; Disease Models, Animal; Female; Humans; Hy | 1974 |
Effect of several models of stress and amphetamine on brain levels of amphetamine and certain monoamines.
Topics: Amphetamine; Animals; Brain; Dextroamphetamine; Disease Models, Animal; Electroshock; Male; Norepine | 1969 |
Homologies for congenital heart diseases: murine models, influenced by dextroamphetamine.
Topics: Animals; Dextroamphetamine; Disease Models, Animal; Female; Heart Septal Defects, Atrial; Heart Sept | 1968 |